Professional Documents
Culture Documents
BY :
KARLINA HARDJAWINATA
DIAGNOSTIC MICROBIOLOGY
The study of specimens taken from
patients suspected of having
infections.
The end result is a report, which
should assist the clinician in reaching a
definitive diagnosis and a decision
on antimicrobial therapy.
The clinicians should be acquainted
with the techniques behind laboratory
analysis.
THE DIAGNOSIS OF AN
INFECTIOUS DISEASE:
Entails a number of decisions and
actions by many people.
The diagnostic cycle begins when the
clinician takes a microbiological
sample and ends when the clinician
receives the laboratory report and
uses the information to manage the
condition.
The steps in the diagnostic cycle area:
identification purposes
Transport media: Specimens are
transported from the clinic to the
laboratory in a transport medium, which
helps to maintain the viability of the
organisms in transit.
Bacteriological transport media: A semisolid
, non-nutrient agar, such as Stuart
transport medium is widely used. It also
contains thioglycolic acid as agent, and
electrolytes.
ATMOSPHERIC REQUIREMENTS
AND INCUBATION
Once inoculated the agar plates may be incubated:
Aerobically: but addition of 10% carbon dioxide
Genetic typing:
A number of novel genetic typing methods are now
available and these produced very accurate ‘fingerprint’
of bacteria.
LABORATORY INVESTIGATIONS RELATED TO
ANTIMICROBIAL THERAPY
Once the putative pathogen has been identified
from a specimen its antimicrobial sensitivity can
be predicted with some degree of accuracy, based
on previous experience and available data.
Prescribing in this manner is called empirical
therapy (e.g. based on the sensitivity of
staphylococcal to flucloxacillin).
However, it is essential to base rational therapy on
the results of laboratory antibiotic tests performed
on the isolated pathogen.
Susceptibility of organisms to
antimicrobial agents
In clinical microbiology a microbe is considered
sensitive (or susceptible) to an antimicrobial agent
if it is inhibited by a concentration of the drug
normally obtained in human tissues after a
standard therapeutic dose.
The reserve is true for a resistant organism.
Organisms are considered intermediate in
susceptibility if the inhibiting concentration of the
antimicrobial agent is slightly higher than that
obtained with a therapeutic dose.
Laboratory testing for
antimicrobial sensitivity
The action of an antimicrobial drug
against an organism can be
measured:
Qualitatively (disc diffusion tests)
concentration or minimum
bactericidal concentration tests).
A semiquantitative technique:
This technique called the break-point
test.
These in vitro tests indicate whether
the expected therapeutic concentration
of the drug given in standard dosage
inhibits the growth of a given
organisms in vivo.
Laboratory results can only give an
indication of the activity of the drug in
vitro.
The activity of the drug in vivo
depend on factors:
The ability of the drug to reach the
site of infection
The immune status of the host. A
strong host defence response may
give the impression of ‘successful’
drug therapy, even though the
infecting organism was ‘resistant’ to a
specific drug when laboratory tests
were used.
DISC DIFFUSION TEST
Is the most commonly used method of
testing the sensitivity of a microorganism
to an antimicrobial agent.
The isolate to be tested is seeded over the
entire surface of an agar plate.
Drug-impregnated filter paper discs are
applied.
After overnight incubation at 37oC, zones of
growth inhibition are observed around each
disc, depending on the sensitivity of a
particular organism to a given agent.
Antimicrobial sensitivity tests
can be divided into:
Primary sensitivity (direct) test
Secondary sensitivity (indirect) test
Primary sensitivity (direct) test:
Primary sensitivity (direct) test is carried out
by inoculating the clinical sample, say pus,
directly on to the test zone of the plate.
The advantage of this is that the overall
sensitivity results for the organisms present in
pus will available after 24-48 hours’
incubation.
This is particularly useful when treating
debilitated patients with acute infections such
as dentoalveolar abscesses.
However this is a rough estimate.
Secondary sensitivity test:
Secondary sensitivity test performed
on a pure culture of the organism
isolated.
The results are not available for at
least 2-4 days after sampling.
Assessment of MIC and MBC:
Determining the minimum inhibitory
concentration (MIC) and the
minimum bactericidal concentration
(MBC) gives a quantitative
assessment of the potency of an
antibiotic.
Method of determining MIC and
MBC:
A range of twofold dilutions of an antimicrobial agent can be
incorporated into a suitable broth in a series of tubes (tube dilution
technique).
The broth is inoculated with a standardized suspension of the test
organism and incubated for 18 hours.
The minimum concentration of the drug that inhibits the growth of the
test organism in the tube is recorded as the MIC, I.e. the lowest
concentration that will inhibit the visible growth in vitro.
Subsequently, a standard inoculum from each of the tubes in which no
growth occurred may be subcultured on blood agar to determine the
minimum concentration of the drug required to kill the organism (MBC).
The MBC is defined as the minimum
concentration of the drug that kills 99,9% of
the test organisms in the original inoculum.
These MIC / MBC tests are not routinely
performed but are useful in patients with
serious infections where optimal antimicrobial
therapy is essential, i.e. to establish sensitivity
of streptococci isolated from blood cultures
from patients with infective endocarditis, and
of bacteria causing septicaemia in
immunosuppressed patients.
APPROPRIATE SPECIMENS FOR ORAL
INFECTIONS:
Sampling for pathogens within the oral environment poses many
problems due to the multitude of indigenous commensal flora that thrive
in the oral cavity.
Many of the patogens are endogenous in origin and cause disease when
an opportunity arises (opportunistic pathogens)
Obtaining an uncontaminated sample from sites such as the depths of
periodontal pockets where the disease activity and hence the numbers of
periodontopathogens are likely to be high is extremely difficult.
For these reasons, judicial and appropriate sampling techniques should
be used when diagnosing oral infections.
The specimens submitted to an oral
microbiology laboratory can be
catagorized as those useful for the
management of:
Purulent infections
Mucosal infections
Periodontal infections
Caries.
Purulent infections:
The appropriate specimen is an
aspirated sample of pus, if possible.
Take care to avoid needlestick
injuries when re-sheathing the
needlecap, drainage of residual pus
by incision, after aspiration sampling,
is obligatory.
The laboratory steps in the
diagnosis of a purulent infection:
Mucosal infections:
A common oral mucosal infection is oral candidiasis.
Here, the lesion is sampled with a dry swab, and a smear
taken immediately thereafter.
When evaluating the oral carriage of yeasts (or other
organisms such as Enterobacteriaceae) then the oral rinse
should be collected.
This entails requesting the patient to rinse the mouth for 60
seconds with 10 ml of phosphate-buffered saline and then
expectorating the rinse into a container, which is transported
to the laboratory for quantification of yeast growth (in term of
CFUs).
Periodontal infections and
caries:
The value of microbiological sampling for the diagnosis
of caries and periodontal diseases is limited.
In the case of dental caries salivary counts of
lactobacilli and Streptococcus mutans could be
used, and for this purpose saliva samples should be
collected.
The diagnosis of periodontal disease by microbiologic
means is problematic. A deep gingival smear is useful
for the diagnosis of acute necrotizing ulcerative
gingivitis, while paper point sample appear useful for
DNA analysis of periodontopathic bacteria.